Behbahani Ali

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-13.4%

median move per position

+9.2%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$15.00M bought · −$255.6K sold

All filings on record

Every Form 4 transaction we track for this filer

All10Buys1Sells0

Stock	Transaction	Date	~6mo vs S&P
GLUEMonte Rosa Therapeutics, Inc.	Other — · 15,000 sh	2026-07-01	—
GLUEMonte Rosa Therapeutics, Inc.	Other — · 15,000 sh	2026-07-01	—
GLUEMonte Rosa Therapeutics, Inc.	Other — · 1,000,000 sh	2026-07-01	—
BDTXBlack Diamond Therapeutics, Inc.	Grant $14.9K · 8,961 sh	2026-06-19	—
SGPSpyGlass Pharma, Inc.	Convert — · 402,273 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 954,990 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Buy $15.00M · 937,500 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 737,962 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 1,370,168 sh	2026-02-09	—
SGPSpyGlass Pharma, Inc.	Convert — · 1,370,168 sh	2026-02-09	—

GLUEOther

2026-07-01 · Monte Rosa Therapeutics, Inc.

15,000

—

GLUEOther

2026-07-01 · Monte Rosa Therapeutics, Inc.

15,000

—

GLUEOther

2026-07-01 · Monte Rosa Therapeutics, Inc.

1,000,000

—

BDTXGrant

2026-06-19 · Black Diamond Therapeutics, Inc.

$14.9K

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

402,273

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

954,990

—

SGPBuy

2026-02-09 · SpyGlass Pharma, Inc.

$15.00M

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

737,962

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

1,370,168

—

SGPConvert

2026-02-09 · SpyGlass Pharma, Inc.

1,370,168

—

Newest 10 of 35 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

BF

Baskett Forest

NEUE · SGP · last 2026-02-09

CC

Chang Carmen

NEUE · SGP · last 2026-02-09

FA

Florence Anthony A. Jr.

NEUE · SGP · last 2026-02-09

MM

Makhzoumi Mohamad

NEUE · SGP · last 2026-02-09

ME

Mathers Edward T

NEUE · SGP · last 2026-02-09

NE

New Enterprise Associates 17, L.P.

NEUE · SGP · last 2026-02-09

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.